vs
Heritage Insurance Holdings, Inc.（HRTG）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
Heritage Insurance Holdings, Inc.的季度营收约是REPLIGEN CORP的1.1倍（$215.3M vs $197.9M），Heritage Insurance Holdings, Inc.净利率更高（31.0% vs 6.7%，领先24.3%），REPLIGEN CORP同比增速更快（13.6% vs 2.4%），Heritage Insurance Holdings, Inc.自由现金流更多（$174.2M vs $17.6M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 6.1%）
该公司是一家位于美国佛罗里达州的财产意外保险公司，在美国多个沿海州开展业务，主要为客户提供商业保险、住宅保险、房主保险以及洪水保险等各类财产意外保障产品。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
HRTG vs RGEN — 直观对比
营收规模更大
HRTG
是对方的1.1倍
$197.9M
营收增速更快
RGEN
高出11.2%
2.4%
净利率更高
HRTG
高出24.3%
6.7%
自由现金流更多
HRTG
多$156.6M
$17.6M
两年增速更快
RGEN
近两年复合增速
6.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $215.3M | $197.9M |
| 净利润 | $66.7M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | 41.6% | 9.0% |
| 净利率 | 31.0% | 6.7% |
| 营收同比 | 2.4% | 13.6% |
| 净利润同比 | 228.6% | 143.9% |
| 每股收益（稀释后） | $2.15 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HRTGRGEN
| Q4 25 | $215.3M | $197.9M | ||
| Q3 25 | $212.5M | $188.8M | ||
| Q2 25 | $208.0M | $182.4M | ||
| Q1 25 | $211.5M | $169.2M | ||
| Q4 24 | $210.3M | $174.1M | ||
| Q3 24 | $211.8M | $154.9M | ||
| Q2 24 | $203.6M | $154.1M | ||
| Q1 24 | $191.3M | $151.3M |
净利润HRTGRGEN
| Q4 25 | $66.7M | $13.3M | ||
| Q3 25 | $50.4M | $14.9M | ||
| Q2 25 | $48.0M | $14.9M | ||
| Q1 25 | $30.5M | $5.8M | ||
| Q4 24 | $20.3M | $-30.3M | ||
| Q3 24 | $8.2M | $-654.0K | ||
| Q2 24 | $18.9M | $3.3M | ||
| Q1 24 | $14.2M | $2.1M |
毛利率HRTGRGEN
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% | ||
| Q1 24 | — | 49.5% |
营业利润率HRTGRGEN
| Q4 25 | 41.6% | 9.0% | ||
| Q3 25 | 33.0% | 8.9% | ||
| Q2 25 | 31.2% | 7.6% | ||
| Q1 25 | 20.1% | 3.9% | ||
| Q4 24 | 15.0% | -17.7% | ||
| Q3 24 | 5.5% | -5.1% | ||
| Q2 24 | 13.6% | 1.0% | ||
| Q1 24 | 11.9% | 1.3% |
净利率HRTGRGEN
| Q4 25 | 31.0% | 6.7% | ||
| Q3 25 | 23.7% | 7.9% | ||
| Q2 25 | 23.1% | 8.2% | ||
| Q1 25 | 14.4% | 3.4% | ||
| Q4 24 | 9.7% | -17.4% | ||
| Q3 24 | 3.8% | -0.4% | ||
| Q2 24 | 9.3% | 2.2% | ||
| Q1 24 | 7.4% | 1.4% |
每股收益（稀释后）HRTGRGEN
| Q4 25 | $2.15 | $0.24 | ||
| Q3 25 | $1.63 | $0.26 | ||
| Q2 25 | $1.55 | $0.26 | ||
| Q1 25 | $0.99 | $0.10 | ||
| Q4 24 | $0.66 | $-0.55 | ||
| Q3 24 | $0.27 | $-0.01 | ||
| Q2 24 | $0.61 | $0.06 | ||
| Q1 24 | $0.47 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $559.3M | $767.6M |
| 总债务越低越好 | $78.4M | $542.2M |
| 股东权益账面价值 | $505.3M | $2.1B |
| 总资产 | $2.2B | $2.9B |
| 负债/权益比越低杠杆越低 | 0.16× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资HRTGRGEN
| Q4 25 | $559.3M | $767.6M | ||
| Q3 25 | $560.4M | $748.7M | ||
| Q2 25 | $473.5M | $708.9M | ||
| Q1 25 | $425.9M | $697.2M | ||
| Q4 24 | $452.7M | $757.4M | ||
| Q3 24 | $509.9M | $784.0M | ||
| Q2 24 | $480.9M | $809.1M | ||
| Q1 24 | $386.1M | $780.6M |
总债务HRTGRGEN
| Q4 25 | $78.4M | $542.2M | ||
| Q3 25 | $79.3M | $537.9M | ||
| Q2 25 | $92.4M | — | ||
| Q1 25 | $94.8M | — | ||
| Q4 24 | $116.3M | $525.6M | ||
| Q3 24 | $118.6M | — | ||
| Q2 24 | $120.8M | — | ||
| Q1 24 | $123.0M | — |
股东权益HRTGRGEN
| Q4 25 | $505.3M | $2.1B | ||
| Q3 25 | $437.3M | $2.1B | ||
| Q2 25 | $383.3M | $2.1B | ||
| Q1 25 | $329.0M | $2.0B | ||
| Q4 24 | $290.8M | $2.0B | ||
| Q3 24 | $279.3M | $2.0B | ||
| Q2 24 | $255.3M | $2.0B | ||
| Q1 24 | $234.9M | $2.0B |
总资产HRTGRGEN
| Q4 25 | $2.2B | $2.9B | ||
| Q3 25 | $2.4B | $2.9B | ||
| Q2 25 | $2.5B | $2.9B | ||
| Q1 25 | $2.2B | $2.9B | ||
| Q4 24 | $2.5B | $2.8B | ||
| Q3 24 | $2.4B | $2.8B | ||
| Q2 24 | $2.6B | $2.9B | ||
| Q1 24 | $2.1B | $2.8B |
负债/权益比HRTGRGEN
| Q4 25 | 0.16× | 0.26× | ||
| Q3 25 | 0.18× | 0.26× | ||
| Q2 25 | 0.24× | — | ||
| Q1 25 | 0.29× | — | ||
| Q4 24 | 0.40× | 0.27× | ||
| Q3 24 | 0.42× | — | ||
| Q2 24 | 0.47× | — | ||
| Q1 24 | 0.52× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $182.2M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $174.2M | $17.6M |
| 自由现金流率自由现金流/营收 | 80.9% | 8.9% |
| 资本支出强度资本支出/营收 | 3.7% | 4.1% |
| 现金转化率经营现金流/净利润 | 2.73× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $337.4M | $93.9M |
8季度趋势，按日历期对齐
经营现金流HRTGRGEN
| Q4 25 | $182.2M | $25.7M | ||
| Q3 25 | $124.3M | $48.1M | ||
| Q2 25 | $43.3M | $28.6M | ||
| Q1 25 | $837.0K | $15.0M | ||
| Q4 24 | $87.1M | $39.2M | ||
| Q3 24 | $-13.4M | $49.3M | ||
| Q2 24 | $152.2M | $42.2M | ||
| Q1 24 | $4.3M | $44.7M |
自由现金流HRTGRGEN
| Q4 25 | $174.2M | $17.6M | ||
| Q3 25 | $122.7M | $43.4M | ||
| Q2 25 | $41.8M | $21.5M | ||
| Q1 25 | $-1.3M | $11.4M | ||
| Q4 24 | $78.9M | $33.6M | ||
| Q3 24 | $-16.3M | $42.3M | ||
| Q2 24 | $149.8M | $37.4M | ||
| Q1 24 | $4.1M | $36.4M |
自由现金流率HRTGRGEN
| Q4 25 | 80.9% | 8.9% | ||
| Q3 25 | 57.8% | 23.0% | ||
| Q2 25 | 20.1% | 11.8% | ||
| Q1 25 | -0.6% | 6.8% | ||
| Q4 24 | 37.5% | 19.3% | ||
| Q3 24 | -7.7% | 27.3% | ||
| Q2 24 | 73.6% | 24.3% | ||
| Q1 24 | 2.1% | 24.0% |
资本支出强度HRTGRGEN
| Q4 25 | 3.7% | 4.1% | ||
| Q3 25 | 0.7% | 2.5% | ||
| Q2 25 | 0.7% | 3.9% | ||
| Q1 25 | 1.0% | 2.1% | ||
| Q4 24 | 3.9% | 3.2% | ||
| Q3 24 | 1.4% | 4.5% | ||
| Q2 24 | 1.2% | 3.1% | ||
| Q1 24 | 0.1% | 5.5% |
现金转化率HRTGRGEN
| Q4 25 | 2.73× | 1.93× | ||
| Q3 25 | 2.47× | 3.23× | ||
| Q2 25 | 0.90× | 1.92× | ||
| Q1 25 | 0.03× | 2.57× | ||
| Q4 24 | 4.29× | — | ||
| Q3 24 | -1.64× | — | ||
| Q2 24 | 8.07× | 12.70× | ||
| Q1 24 | 0.30× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
